These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9773094)

  • 1. [Do 'chondroprotective agents' agents exist in osteoarthritis? Required proof].
    Lequesne M; Cadet C
    Therapie; 1998; 53(1):7-16. PubMed ID: 9773094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subchondral bone in osteoarthritis physiopathology: state-of-the art and perspectives.
    Henrotin Y; Pesesse L; Sanchez C
    Biomed Mater Eng; 2009; 19(4-5):311-6. PubMed ID: 20042798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the potential use of calcitonin in osteoarthritis.
    Manicourt DH; Devogelaer JP; Azria M; Silverman S
    J Musculoskelet Neuronal Interact; 2005; 5(3):285-93. PubMed ID: 16172519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for testing slow acting drugs in osteoarthritis.
    Lequesne M; Brandt K; Bellamy N; Moskowitz R; Menkes CJ; Pelletier JP; Altman R
    J Rheumatol Suppl; 1994 Sep; 41():65-71; discussion 72-3. PubMed ID: 7799389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoarthritis: a tale of three tissues.
    Samuels J; Krasnokutsky S; Abramson SB
    Bull NYU Hosp Jt Dis; 2008; 66(3):244-50. PubMed ID: 18937640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel drug treatment strategies for osteoarthritis.
    Creamer P; Dieppe PA
    J Rheumatol; 1993 Sep; 20(9):1461-4. PubMed ID: 8164198
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological markers in osteoarthritis.
    Rousseau JC; Delmas PD
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):346-56. PubMed ID: 17538566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroprotective drugs in degenerative joint diseases.
    Verbruggen G
    Rheumatology (Oxford); 2006 Feb; 45(2):129-38. PubMed ID: 16278282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
    Ding M; Danielsen CC; Hvid I
    Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular markers of osteoarthritis].
    Senolt L; Pavelka K
    Acta Chir Orthop Traumatol Cech; 2005; 72(3):191-6. PubMed ID: 16105504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of bone in osteoarthritis pathogenesis.
    Goldring SR
    Med Clin North Am; 2009 Jan; 93(1):25-35, xv. PubMed ID: 19059019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoarthritis.
    Mahajan A; Verma S; Tandon V
    J Assoc Physicians India; 2005 Jul; 53():634-41. PubMed ID: 16190135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarticular drug delivery in osteoarthritis.
    Gerwin N; Hops C; Lucke A
    Adv Drug Deliv Rev; 2006 May; 58(2):226-42. PubMed ID: 16574267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging can accurately assess the long-term progression of knee structural changes in experimental dog osteoarthritis.
    Boileau C; Martel-Pelletier J; Abram F; Raynauld JP; Troncy E; D'Anjou MA; Moreau M; Pelletier JP
    Ann Rheum Dis; 2008 Jul; 67(7):926-32. PubMed ID: 17962236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of evaluating chondroprotective treatment].
    Dougados M; Duchesne L
    Rev Prat; 1989 Mar; 39(7):575-7. PubMed ID: 2704969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
    Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of bone in osteoarthritis pathogenesis.
    Goldring SR
    Rheum Dis Clin North Am; 2008 Aug; 34(3):561-71. PubMed ID: 18687272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin.
    Flannery CR; Zollner R; Corcoran C; Jones AR; Root A; Rivera-Bermúdez MA; Blanchet T; Gleghorn JP; Bonassar LJ; Bendele AM; Morris EA; Glasson SS
    Arthritis Rheum; 2009 Mar; 60(3):840-7. PubMed ID: 19248108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.